SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant post-earnings reaction, as its Q1 guidance, despite some strong Q4 results, has triggered a sharp sell-off and community debate. Many view this as a healthy correction or a buying opportunity, emphasizing the company's long-term turnaround strategy and strategic national importance with government backing. Conversely, others point to ongoing competitive pressures, high valuation, and future sales traction not expected until 2026/2027, leading to a bearish outlook.

RYVYL Inc. is a financial technology company that develops software platforms and tools that are focused on providing global payment acceptance and disbursement capabilities. It offers an innovative payment platform-as-a-service that redefines global payment solutions, enabling seamless business-to-business, consumer-to-business, and peer-to-peer transactions worldwide. The company leverages advanced electronic payment technology to deliver seamless financial solutions across global markets. It operates through two geographical segments: North America and International. The company was founded on April 10, 2007 and is headquartered in San Diego, CA.

Ryvyl Inc

RVYL is actively trending as the community closely monitors developments surrounding its merger with Roundtable and a recent reverse stock split. The low public float and progression towards Nasdaq compliance, alongside new strategic partnerships such as a notable deal with The Hockey News, are fueling discussions about potential short squeeze opportunities. Traders are keenly debating the company's post-merger valuation and the vision for its Web3 digital media and Bitcoin treasury ecosystem.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending due to significant community discussion surrounding its MASH treatment, pemvidutide, which holds Breakthrough Therapy Designation from the FDA and is perceived as a "best-in-class" asset in the booming obesity and liver disease market. Investors are keenly anticipating a potential partnership or buyout, driven by the drug's differentiated profile, the new CEO's M&A experience, and high short interest, leading to widespread speculation of a substantial re-rating and short squeeze.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is generating significant buzz due to its extremely low share float, fueling intense speculation around a potential short squeeze. While many in the community are anticipating a rapid, parabolic breakout, others caution against a pump-and-dump scheme, citing the company's publicly acknowledged strategic review and discontinued operations. This dynamic has positioned SNSE as a highly volatile micro-cap, attracting traders focused on short-term, speculative price movements.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano is trending following its announced merger with Corvex, an AI cloud computing firm that secured a long-term deployment of NVIDIA H200 GPUs for its infrastructure. The community is sharply divided, with many anticipating a significant short squeeze driven by the low share float and AI sector interest, while others caution that the NVIDIA connection is overblown and fear potential dilution.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing intense market attention following impressive weekly prescription data for its oral Wegovy, which significantly surpassed analyst expectations. Community discussion highlights the "magic pill" as a transformative advantage, solidifying NVO's leadership in the rapidly expanding GLP-1 sector and drawing comparisons to top-tier valuations. This momentum, amplified by confidence in its market position and clarity on tariff protections, is fueling widespread bullish sentiment.

Movement Network is a secure and scalable blockchain designed to make Move programming accessible to developers everywhere. With high-performance execution and security, Movement delivers the infrastructure for the next generation of decentralized applications and unleashes opportunity and financial empowerment for anyone, anywhere.  $MOVE is the native token of Movement Network, for transaction fees and staking to secure the network. The Movement M1 (Layer 1) Network is powered by the Move programming language, unleashing opportunity, accessibility, and financial empowerment for anyone, anywhere.

MarketMove

MarketMove is trending significantly after its merger partner, Corvex, announced a long-term NVIDIA H200 GPU deployment with an AI-driven battery technology provider. This key development positions the combined entity as a player in secure AI infrastructure, sparking widespread community excitement about its enhanced growth prospects and strategic pivot into high-performance AI platforms. Investors are closely following this shift, anticipating continued momentum fueled by interest in cutting-edge technology.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BTGO is actively discussed post-IPO, with the community debating its initial market performance. While some are concerned by early dips, many are optimistic, citing its unique position as a 'pure-play' institutional crypto custodian with strong regulatory standing and a tight share float as potential drivers for long-term appreciation.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is trending after its recent Q3 earnings exceeded expectations, highlighting strong user growth and improved margins, alongside analyst upgrades that underscore long-term potential from AI-driven features and new content like music videos. However, recent subscription price increases and reports of a significant data leak are active community talking points. Many investors are also observing the stock's perceived correlation with broader tech market and Netflix movements, adding to its current volatility.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is trending as its consistent strong earnings performance, fueled by robust inside sales and strategic acquisitions, continues to impress. The community highlights its unique convenience store model, particularly its popular food offerings, seeing it as a resilient long-term growth and dividend play in the expanding retail sector, despite ongoing discussions about its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FUL Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.55 up 523.08% YoY
• Reported revenue of $894.79M down -3.09% YoY
• H.B. Fuller expects fiscal 2026 net revenue to be flat to up 2%, with adjusted EBITDA in the range of $630 million to $660 million, and adjusted EPS (diluted) between $4.35 and $4.70.

Stocktwits

H.B. Fuller Company

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.55 up 523.08% YoY
• Reported revenue of $894.79M down -3.09% YoY
• H.B. Fuller expects fiscal 2026 net revenue to be flat to up 2%, with adjusted EBITDA in the range of $630 million to $660 million, and adjusted EPS (diluted) between $4.35 and $4.70.